258 related articles for article (PubMed ID: 31239543)
21. Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells.
Aoshima K; Fukui Y; Gulay KCM; Erdemsurakh O; Morita A; Kobayashi A; Kimura T
BMC Vet Res; 2018 Oct; 14(1):301. PubMed ID: 30285832
[TBL] [Abstract][Full Text] [Related]
22. FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node.
Lee GH; Yoo KC; An Y; Lee HJ; Lee M; Uddin N; Kim MJ; Kim IG; Suh Y; Lee SJ
Oncogene; 2018 Apr; 37(14):1857-1868. PubMed ID: 29348460
[TBL] [Abstract][Full Text] [Related]
23. The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.
Huang TT; Ping YH; Wang AM; Ke CC; Fang WL; Huang KH; Lee HC; Chi CW; Yeh TS
Oncotarget; 2015 Jul; 6(20):18012-26. PubMed ID: 26041881
[TBL] [Abstract][Full Text] [Related]
24. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
[TBL] [Abstract][Full Text] [Related]
25. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
[TBL] [Abstract][Full Text] [Related]
26. Hierarchy of breast cancer cells: key to reverse dormancy for therapeutic intervention.
Bliss SA; Greco SJ; Rameshwar P
Stem Cells Transl Med; 2014 Jul; 3(7):782-6. PubMed ID: 24833590
[TBL] [Abstract][Full Text] [Related]
27. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
[TBL] [Abstract][Full Text] [Related]
28. The Endosteal Niche in Breast Cancer Bone Metastasis.
Haider MT; Smit DJ; Taipaleenmäki H
Front Oncol; 2020; 10():335. PubMed ID: 32232008
[TBL] [Abstract][Full Text] [Related]
29. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
30. Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis.
Angeloni V; Contessi N; De Marco C; Bertoldi S; Tanzi MC; Daidone MG; Farè S
Acta Biomater; 2017 Nov; 63():306-316. PubMed ID: 28927931
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
[TBL] [Abstract][Full Text] [Related]
32. The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization.
Lévesque JP; Helwani FM; Winkler IG
Leukemia; 2010 Dec; 24(12):1979-92. PubMed ID: 20861913
[TBL] [Abstract][Full Text] [Related]
33. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow.
Bliss SA; Sinha G; Sandiford OA; Williams LM; Engelberth DJ; Guiro K; Isenalumhe LL; Greco SJ; Ayer S; Bryan M; Kumar R; Ponzio NM; Rameshwar P
Cancer Res; 2016 Oct; 76(19):5832-5844. PubMed ID: 27569215
[TBL] [Abstract][Full Text] [Related]
35. Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis.
Dai R; Liu M; Xiang X; Xi Z; Xu H
J Exp Clin Cancer Res; 2022 Oct; 41(1):316. PubMed ID: 36307871
[TBL] [Abstract][Full Text] [Related]
36. Balancing dormant and self-renewing hematopoietic stem cells.
Wilson A; Laurenti E; Trumpp A
Curr Opin Genet Dev; 2009 Oct; 19(5):461-8. PubMed ID: 19811902
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of Notch2(+) pancreatic cancer stem-like cells and the relationship with centroacinar cells.
Zhou ZC; Dong QG; Fu DL; Gong YY; Ni QX
Cell Biol Int; 2013 Aug; 37(8):805-11. PubMed ID: 23536545
[TBL] [Abstract][Full Text] [Related]
38. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
39. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
40. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
